EUVIMEDEUVIMED entdecken
Open Access

SARS-CoV-2 Screening Testing Programs for Safe In-person Learning in K–12 Schools

Ibukunoluwa C Kalu, Kanecia O Zimmerman, Jennifer L Goldman, Dana Keener Mast, Ashley M Blakemore, Ganga Moorthy, Angelique E Boutzoukas, Melissa M Campbell, Diya Uthappa, Jesse DeLaRosa, Jessica M Potts, Laura J Edwards und 4 weitere

Journal of the Pediatric Infectious Diseases Society · 2023

DOI: 10.1093/jpids/piac119 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Pediatric Infectious Diseases Society, 2023. Verfasst von Ibukunoluwa C Kalu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) screening testing is a recommended mitigation strategy for schools, although few descriptions of program implementation are available.

Methods

Kindergarten through 12th grade (K–12) students and staff practicing universal masking during the delta and omicron variant waves from five schools in Durham, North Carolina and eight schools in Kansas City, Missouri participated; Durham’s program was structured as a public health initiative facilitated by school staff, and Kansas City’s as a research study facilitated by a research team. Tests included school-based rapid antigen or polymerase chain reaction testing, at-home rapid antigen testing, and off-site nucleic acid amplification testing.

Results

We performed nearly 5700 screening tests on more than 1600 K–12 school students and staff members. The total cost for the Durham testing program in 5 public charter K–12 schools, each with 500–1000 students, was $246 587 and approximately 752 h per semester; cost per test was $70 and cost per positive result was $7076. The total cost for the Kansas City program in eight public K–12 schools was $292 591 and required approximately 537 h in personnel time for school-based testing; cost per test was $132 and cost per positive result was $4818. SARS-CoV-2 positivity rates were generally lower (0–16.16%) than rates in the community (2.7–36.47%) throughout all testing weeks. Conclusions and Relevance Voluntary screening testing programs in K–12 schools are costly and rarely detect asymptomatic positive persons, particularly in universally masked settings. Clinical Trial Registration NCT04831866.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansSchoolsEducational Status

Stichwörter der Autor:innen

K–12 school communitiesSARS-CoV-2screening testing

Autor:innen und Institutionen

  • Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA.
  • The ABC Science Collaborative, Durham, North Carolina, USA.
  • ICF, Atlanta, Georgia, USA.
  • Department of Pediatrics, Division of Pediatric Infectious Diseases, Children's Mercy Kansas City, University of Missouri, Kansas City, Kansas City, Missouri, USA.
  • Duke University School of Medicine, Doctor of Medicine Program, Durham, North Carolina, USA.

ORCID-Profile: Rangaraj Selvarangan

Förderung

  • NICHD NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • Trial Innovation Network
  • National Institute of Child Health and Human Development

Zitieren

APA

Kalu, I. C., Zimmerman, K. O., Goldman, J. L., Keener Mast, D., Blakemore, A. M., Moorthy, G., Boutzoukas, A. E., Campbell, M. M., Uthappa, D., DeLaRosa, J., Potts, J. M., Edwards, L. J., Selvarangan, R., Benjamin, D. K., Mann, T. K., & Schuster, J. E. (2023). SARS-CoV-2 Screening Testing Programs for Safe In-person Learning in K–12 Schools. Journal of the Pediatric Infectious Diseases Society. https://doi.org/10.1093/jpids/piac119

Vancouver

Kalu IC, Zimmerman KO, Goldman JL, Keener Mast D, Blakemore AM, Moorthy G, et al. SARS-CoV-2 Screening Testing Programs for Safe In-person Learning in K–12 Schools. Journal of the Pediatric Infectious Diseases Society. 2023. doi:10.1093/jpids/piac119

BibTeX
@article{Kalu2023,
  author = {Kalu, Ibukunoluwa C and Zimmerman, Kanecia O and Goldman, Jennifer L and Keener Mast, Dana and Blakemore, Ashley M and Moorthy, Ganga and Boutzoukas, Angelique E and Campbell, Melissa M and Uthappa, Diya and DeLaRosa, Jesse and Potts, Jessica M and Edwards, Laura J and Selvarangan, Rangaraj and Benjamin, Daniel K and Mann, Tara K and Schuster, Jennifer E},
  title = {SARS-CoV-2 Screening Testing Programs for Safe In-person Learning in K–12 Schools},
  journal = {Journal of the Pediatric Infectious Diseases Society},
  year = {2023},
  doi = {10.1093/jpids/piac119}
}
Kostenlos starten →